BRPI1009823A2 - "composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit." - Google Patents

"composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit."

Info

Publication number: BRPI1009823A2
Authority: BR; Brazil
Prior art keywords: composition; kit; dispensing system; drug dispensing; composition set
Prior art date: 2009-03-13

Application number

BRPI1009823A

Other languages

English (en)

Inventor

Andremont Antoine

Lescure François

De Gunzburg Jean

Original Assignee

Da Volterra Assistance Publique Hopitaux De Paris E Univ Paris Diderot Paris 7

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-03-13

Filing date

2010-03-12

Publication date

2019-09-24

2010-03-12 Application filed by Da Volterra Assistance Publique Hopitaux De Paris E Univ Paris Diderot Paris 7 filed Critical Da Volterra Assistance Publique Hopitaux De Paris E Univ Paris Diderot Paris 7

2019-09-24 Publication of BRPI1009823A2 publication Critical patent/BRPI1009823A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Transplantation (AREA)
Virology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

BRPI1009823A 2009-03-13 2010-03-12 "composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit." BRPI1009823A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US16016209P	2009-03-13	2009-03-13
PCT/EP2010/053231 WO2010103119A1 (en)	2009-03-13	2010-03-12	Compositions and methods for elimination of gram-negative bacteria

Publications (1)

Publication Number	Publication Date
BRPI1009823A2 true BRPI1009823A2 (pt)	2019-09-24

Family

ID=42153903

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1009823A BRPI1009823A2 (pt)	2009-03-13	2010-03-12	"composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit."

Country Status (12)

Country	Link
US (1)	US20120058936A1 (pt)
EP (1)	EP2405909A1 (pt)
JP (1)	JP2012520268A (pt)
KR (1)	KR20120004448A (pt)
CN (1)	CN102413826A (pt)
AU (1)	AU2010223233A1 (pt)
BR (1)	BRPI1009823A2 (pt)
CA (1)	CA2754604A1 (pt)
EA (1)	EA201101319A1 (pt)
IL (1)	IL214979A0 (pt)
MX (1)	MX2011009548A (pt)
WO (1)	WO2010103119A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2011151941A1 (ja)	2010-06-04	2011-12-08	国立大学法人東京大学	制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
WO2012061902A1 (en) *	2010-11-12	2012-05-18	Monash University	Micronised spray-dried particles comprising polymyxin
WO2012085241A1 (en)	2010-12-22	2012-06-28	Da Volterra	Compositions and methods for the controlled repopulation of gram-negative bacteria in the colon
FI3978598T3 (fi)	2011-12-01	2024-11-12	Univ Tokyo	Ihmisperäisiä bakteereja, jotka indusoivat regulatoristen t-solujen proliferaatiota tai kertymistä
CN103130881B (zh) *	2013-02-06	2014-09-10	王冬国	一种肺炎克雷伯菌的耐药新基因
WO2015112977A1 (en) *	2014-01-27	2015-07-30	Susanne Gardner	Antimicrobial formulations and applications thereof
CA3018328A1 (en)	2014-10-31	2016-04-30	Purdue Pharma	Methods and compositions particularly for treatment of attention deficit disorder
KR101995622B1 (ko) *	2015-04-03	2019-07-02	건국대학교 글로컬산학협력단	Adk 단백질을 유효성분으로 포함하는 카바페넴 내성 그람음성균에 대한 항균용 조성물
US11174288B2 (en)	2016-12-06	2021-11-16	Northeastern University	Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
CN107184953A (zh) *	2017-05-22	2017-09-22	山东省科学院生物研究所	一种抗菌脂肽皮脂膜修复组合物及其应用
US10722473B2 (en)	2018-11-19	2020-07-28	Purdue Pharma L.P.	Methods and compositions particularly for treatment of attention deficit disorder
CN110179967A (zh) *	2019-05-28	2019-08-30	中国医药集团总公司四川抗菌素工业研究所	多粘菌素母核和一种抗生素的组合物及其应用
CN116437929B (zh) *	2020-07-02	2025-11-11	普渡研究基金会	抗微生物化合物的吸入制剂
CN112316112A (zh) *	2020-11-30	2021-02-05	河南农业大学	阿奇霉素在逆转食品动物源致病菌抗生素耐药性的用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3494308A (en)	1967-11-14	1970-02-10	George S Perrin	Composite article having portions simulating wood
US4474768A (en)	1982-07-19	1984-10-02	Pfizer Inc.	N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
RO107257B1 (ro)	1987-07-09	1993-10-30	Pfizer	Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
US6235313B1 (en)	1992-04-24	2001-05-22	Brown University Research Foundation	Bioadhesive microspheres and their use as drug delivery and imaging systems
US5840332A (en) *	1996-01-18	1998-11-24	Perio Products Ltd.	Gastrointestinal drug delivery system
US6245903B1 (en)	1998-08-21	2001-06-12	Apotex, Inc.	Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
RO121408B1 (ro)	1998-11-30	2007-05-30	Teva Pharmaceutical Industries Ltd.	Etanolat de azitromicină, procedeu de obţinere şi compoziţii farmaceutice ale acestuia
HRP20010956B1 (hr)	1999-06-29	2010-09-30	Biochemie S.A.	Makrolidi
PT1246831E (pt)	2000-01-04	2008-03-28	Teva Pharma	Método de preparação de di-hidrato de azitromicina
DE60026718T2 (de)	2000-07-25	2006-11-16	Laboratorio Silanes, S.A. De C.V.	Einstufiges verfahren zur herstellung von 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle(11.2.11)hexadeca-1(2)-en-8-ona undeine neue form von 9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a
ES2172417B1 (es)	2000-07-31	2003-09-16	Sint Quimica Sa	Nueva forma mejorada de azitromicina monohidrato de menor higroscopicidad, procedimiento de preparacion y composiciones farmaceuticas que la comprenden.
CA2419873A1 (en)	2000-08-23	2002-02-28	Wockhardt Limited	Process for preparation of anhydrous azithromycin
HRP20030430B1 (hr)	2000-11-27	2011-11-30	Biochemie S.A.	Makrolidni solvati
AU2002256846B2 (en)	2001-05-22	2007-04-05	Pfizer Products Inc.	Crystal Forms of Azithromycin
WO2006045156A1 (en) *	2004-10-29	2006-05-04	Monash University	Therapy for multi-drug resistant microorganisms
US9149439B2 (en) *	2005-03-21	2015-10-06	Sandoz Ag	Multi-particulate, modified-release composition
WO2008076806A2 (en) *	2006-12-15	2008-06-26	Trustees Of Boston University	Compositions and methods to potentiate colistin activity
DE102007009242A1 (de)	2007-02-22	2008-09-18	Evonik Röhm Gmbh	Pellets mit magensaftresistenter Wirkstoff-Matix
US20100239682A1 (en) *	2007-09-17	2010-09-23	Antoine Andremont	Colonic delivery of antimicrobial agents

2010
- 2010-03-12 CA CA2754604A patent/CA2754604A1/en not_active Abandoned
- 2010-03-12 WO PCT/EP2010/053231 patent/WO2010103119A1/en not_active Ceased
- 2010-03-12 JP JP2011553474A patent/JP2012520268A/ja not_active Withdrawn
- 2010-03-12 BR BRPI1009823A patent/BRPI1009823A2/pt not_active IP Right Cessation
- 2010-03-12 US US13/256,220 patent/US20120058936A1/en not_active Abandoned
- 2010-03-12 MX MX2011009548A patent/MX2011009548A/es not_active Application Discontinuation
- 2010-03-12 EP EP10708768A patent/EP2405909A1/en not_active Withdrawn
- 2010-03-12 CN CN2010800194632A patent/CN102413826A/zh active Pending
- 2010-03-12 KR KR1020117024134A patent/KR20120004448A/ko not_active Withdrawn
- 2010-03-12 EA EA201101319A patent/EA201101319A1/ru unknown
- 2010-03-12 AU AU2010223233A patent/AU2010223233A1/en not_active Abandoned
2011
- 2011-09-05 IL IL214979A patent/IL214979A0/en unknown

Also Published As

Publication number	Publication date
CN102413826A (zh)	2012-04-11
WO2010103119A1 (en)	2010-09-16
JP2012520268A (ja)	2012-09-06
KR20120004448A (ko)	2012-01-12
EA201101319A1 (ru)	2012-04-30
US20120058936A1 (en)	2012-03-08
CA2754604A1 (en)	2010-09-16
AU2010223233A1 (en)	2011-10-06
EP2405909A1 (en)	2012-01-18
IL214979A0 (en)	2011-11-30
MX2011009548A (es)	2011-12-14

Publication	Publication Date	Title
BRPI1009823A2 (pt)	2019-09-24	"composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit."
BRPI1010768A2 (pt)	2016-11-01	composto, e, composição farmacêutica.
BRPI0910503A2 (pt)	2015-09-29	compostos, composições farmacêuticas e respectivos usos.
DK1907037T3 (da)	2019-10-21	Medikamentdispenser.
BRPI0810646A2 (pt)	2014-11-04	" compostos farmacêuticos ".
IL206395A (en)	2015-04-30	N- Heterocyclic-7-Oxo-6-Sulphoxy-6,1-Diazabicyclo [1.2.3] Octane-2-Carboxamides and Pharmaceuticals Containing Them
BRPI0815773A2 (pt)	2019-09-24	composto, e, medicamento.
IL211400A0 (en)	2011-05-31	Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
BRPI0815709A2 (pt)	2017-06-13	composro, composição farmacêutica, e, uso de um composto.
BRPI0906962A2 (pt)	2015-07-14	Composto, e, composição farmacêutica
BRPI0906556A2 (pt)	2015-07-07	Composto, e, composição farmacêutica
BRPI0715712A2 (pt)	2014-06-24	Composição farmacêutica
DK2073795T3 (da)	2014-02-03	Misbrugssikret lægemiddelformulation
NL2000690A1 (nl)	2007-12-11	Gestabiliseerde farmaceutische samenstellingen omvattende fesoterodine.
BRPI0812354A2 (pt)	2015-01-27	Composição farmacêutica não-aquosa.
BRPI0719393A2 (pt)	2015-03-31	Composição farmacêutica
BR112012004335A2 (pt)	2015-09-08	composto, composição farmacêutica, e, uso do composto.
BR112012003800A2 (pt)	2016-11-22	composição, peptídeo, e formulação farmacêutica.
BRPI0917681A2 (pt)	2015-08-04	Composto, e, composição farmacêutica
IL206808A (en)	2015-08-31	Indolyl-pyridone history, their pharmaceutical preparations and their uses
BRPI0807078A2 (pt)	2014-04-08	Composto, e, formulação farmacêutica
BRPI0716445A2 (pt)	2013-09-17	composiÇço farmacÊutica
BRPI0720234A2 (pt)	2013-12-24	Composição farmacêutica
BRPI1009392A2 (pt)	2016-03-08	"formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
BRPI0911772A2 (pt)	2017-06-27	composto, composição farmacêutica, e, uso do composto.

Legal Events

Date	Code	Title	Description
2019-10-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2020-01-21	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.